Form 4: Amgen Director Brian Druker Reports Acquisition of Common Stock

Director Brian Druker reports acquisition of 719 shares of Amgen common stock on May 31, 2024, through vested Restricted Stock Units (RSUs) and dividend equivalents.

Summary

• On May 31, 2024, Brian Druker, a director of Amgen Inc., acquired 719 shares of Amgen common stock.
• The acquisition was made through the vesting of Restricted Stock Units (RSUs) granted under the Amgen Inc. 2009 Director Incentive Program.
• The vested RSUs are paid in shares of the company's common stock on a one-to-one basis.
• The reported transaction also includes 471 Dividend Equivalents (DEs) granted pursuant to the Director Program.
• Following the transaction, Druker beneficially owns 6,472 shares of Amgen common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock acquisition by a director, indicating confidence but not necessarily a major event.

Positives

• The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it signals confidence from a company director.

Key Dates